|
Post by porkini on Dec 13, 2018 12:40:20 GMT -5
I'm guessing that MNKD did not instruct Zacks SCR how to write the report and how to come up with a value. Zacks SCR is, after all, putting the article out there with their name on it and whatever reputation they have on the line... I don't disagree, and FWIW I never claimed MNKD told Zacks SCR what to write, or that they did not stand behind their price target. Whoever claimed you claimed that should be flogged with wet noodles! I was hoping that I was adding support to your mnkdfann and also mannmade comments by putting the previously (in this thread) unnamed price target out there for those who did not go to the report to read it yet. It was part of the title of the Yahoo article, but I thought the inclusion of source as part of Zacks SCR important. My apologies if I somehow missed that mark and hope the remainder of everyone's day today is awesome!
|
|
|
Post by mnholdem on Dec 13, 2018 17:49:07 GMT -5
Excerpt from Zacks report:
ANALYST DISCLOSURES
I, Brian Marckx, CFA, hereby certify that the view expressed in this research report accurately reflect my personal views about the subject securities and issuers. I also certify that no part of my compensation was, is, or will be, directly or indirectly, related to the recommendations or views expressed in this research report. I believe the information used for the creation of this report has been obtained from sources I considered to be reliable, but I can neither guarantee nor represent the completeness or accuracy of the information herewith. Such information and the opinions expressed are subject to change without notice.
|
|
|
Zacks
Dec 13, 2018 19:56:21 GMT -5
Post by traderdennis on Dec 13, 2018 19:56:21 GMT -5
I saw the article pop up on my main page Yahoo feed, but that's mostly just because of how well Yahoo/Google knows me. Of course I stupidly checked the comments section and saw the usual mess of "OMG PAID REPORT, FAKE NEWS!!!!", "MNKD SUCKZZZ, GOING BANKRUPT!!!" The report is NOT fake news, but according to the disclosures it WAS paid for my Mannkind or its agent: "Zacks SCR has received compensation from the issuer directly or from an investor relations consulting firm engaged by the issuer for providing non-investment banking services to this issuer and expects to receive additional compensation for such non-investment banking services provided to this issuer. The non-investment banking services provided to the issuer includes the preparation of this report, investor relations services, investment software, financial database analysis, organization of non-deal road shows, and attendance fees for conferences sponsored or co-sponsored by Zacks SCR. The fees for these services vary on a per-client basis and are subject to the number and types of services contracted. Fees typically range between ten thousand and fifty thousand dollars per annum. Details of fees paid by this issuer are available upon request." While some might view that as discouraging, the optimist may take it as encouraging in the sense this may indicate that Mannkind is very interested in actively protecting its pumping share price, and may use other promotional tools of the trade to get the share price high enough and soon enough for the outstanding warrants to be exercised or prepare for a pipe funding.
|
|
|
Post by mnkdfann on Dec 13, 2018 20:06:13 GMT -5
The report is NOT fake news, but according to the disclosures it WAS paid for my Mannkind or its agent: "Zacks SCR has received compensation from the issuer directly or from an investor relations consulting firm engaged by the issuer for providing non-investment banking services to this issuer and expects to receive additional compensation for such non-investment banking services provided to this issuer. The non-investment banking services provided to the issuer includes the preparation of this report, investor relations services, investment software, financial database analysis, organization of non-deal road shows, and attendance fees for conferences sponsored or co-sponsored by Zacks SCR. The fees for these services vary on a per-client basis and are subject to the number and types of services contracted. Fees typically range between ten thousand and fifty thousand dollars per annum. Details of fees paid by this issuer are available upon request." While some might view that as discouraging, the optimist may take it as encouraging in the sense this may indicate that Mannkind is very interested in actively protecting its pumping share price, and may use other promotional tools of the trade to get the share price high enough and soon enough for the outstanding warrants to be exercised or prepare for a pipe funding. If someone is going to change someone else's words, I wish they would do it outside of the quote level. I know you mean no harm, but there are people on this board who are now going to think I said those things you highlighted.
|
|
|
Post by traderdennis on Dec 19, 2018 16:44:49 GMT -5
Now we know why the company employed Zacks to pump the stock. See new shelf offering
|
|
|
Post by mnkdfann on Dec 19, 2018 19:30:34 GMT -5
Now we know why the company employed Zacks to pump the stock. See new shelf offering Sure looks that way. And boy do I sure look sharp now, having seemingly predicted a share offering a few posts above.
|
|
|
Zacks
Dec 19, 2018 20:27:18 GMT -5
via mobile
Post by traderdennis on Dec 19, 2018 20:27:18 GMT -5
Now we know why the company employed Zacks to pump the stock. See new shelf offering Sure looks that way. And boy do I sure look sharp now, having seemingly predicted a share offering a few posts above. I actually don’t think the company paid for the ad on zacks. I am 99.99 percent certain it is the pipe funding underwriter leerink (sp)
|
|
|
Zacks
Dec 19, 2018 20:31:41 GMT -5
Post by mnkdfann on Dec 19, 2018 20:31:41 GMT -5
I actually don’t think the company paid for the ad on zacks. I am 99.99 percent certain it is the pipe funding underwriter leerink (sp) I feel sorry for Zacks analysts Brian Marckx, CFA and Anita Dushyanth, PhD who wrote the ad. Assuming the analyst disclosure is true ("Zacks SCR Analysts hereby certify that the view expressed in this research report or blog article accurately reflect the personal views of the analyst about the subject securities and issuers"), they must feel dirty and used this evening. Well, I suppose it is a part of their job.
|
|
|
Post by mnholdem on Dec 19, 2018 21:55:13 GMT -5
What if this is a buy-in? _________ shares @ $______ per share in private placement to a single company? Technosphere is real and gaining credibility with the medical community. It's unlikely that United Therapeutics is the only pharmaceutical company that's been paying attention.
|
|
|
Zacks
Dec 19, 2018 22:00:30 GMT -5
Post by mnkdfann on Dec 19, 2018 22:00:30 GMT -5
Fingers crossed.
|
|
|
Zacks
Dec 19, 2018 23:19:42 GMT -5
Post by tomtabb on Dec 19, 2018 23:19:42 GMT -5
What if this is a buy-in? _________ shares @ $______ per share in private placement to a single company? Technosphere is real and gaining credibility with the medical community. It's unlikely that United Therapeutics is the only pharmaceutical company that's been paying attention. To me, the problem with your statement is the "what if"? They must have known the impact this would have on the stock price. Why didn't they offer up some explanation with it? I don't see that the SEC filing offers much -- www.sec.gov/Archives/edgar/data/899460/000119312518353255/d654787d424b5.htmOne thing I did find curious was it says "Our authorized capital stock consists of 550,000,000 shares of common stock." I thought they had only like 280,000,000 shares authorized.
|
|
|
Post by mnkdfann on Dec 19, 2018 23:27:17 GMT -5
What if this is a buy-in? _________ shares @ $______ per share in private placement to a single company? Technosphere is real and gaining credibility with the medical community. It's unlikely that United Therapeutics is the only pharmaceutical company that's been paying attention. To me, the problem with your statement is the "what if"? They must have known the impact this would have on the stock price. Why didn't they offer up some explanation with it? I don't see that the SEC filing offers much -- www.sec.gov/Archives/edgar/data/899460/000119312518353255/d654787d424b5.htmOne thing I did find curious was it says "Our authorized capital stock consists of 550,000,000 shares of common stock." I thought they had only like 280,000,000 shares authorized. Aged wrote: "The summary prospectus doesn't have any numbers and looks largely like a boilerplate ..." With numbers missing, it is clear it needs to still be edited and corrected. Corrections may include the possibly incorrect number you mentioned. I don't understand how / why something incomplete like this gets filed in the first place.
|
|
|
Zacks
Dec 20, 2018 10:11:42 GMT -5
Post by orlon on Dec 20, 2018 10:11:42 GMT -5
Off to a good start at $1.15 towards that goal! Ever wonder how this company meets payroll?
|
|
|
Zacks
Dec 20, 2018 12:34:18 GMT -5
Post by traderdennis on Dec 20, 2018 12:34:18 GMT -5
Off to a good start at $1.15 towards that goal! Ever wonder how this company meets payroll? They are great at diluting shareholder equity to meet company payroll.
|
|
|
Zacks
Dec 20, 2018 17:57:41 GMT -5
Post by mnholdem on Dec 20, 2018 17:57:41 GMT -5
My idea has become moot and the CEO pretty much blew my suggestion out of the water when MannKind priced the offering.
|
|